Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use.
J Clin Pharm Ther
; 47(1): 97-103, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34668200
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiotensin-Converting Enzyme Inhibitors
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Diabetes Mellitus, Type 2
/
Angiotensin Receptor Antagonists
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Pharm Ther
Journal subject:
FARMACIA
/
TERAPEUTICA
Year:
2022
Document type:
Article
Country of publication: